Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.

MLA

Udelsman, Brooks V., et al. “Overall Survival in Low-Comorbidity Patients with Stage I Non-Small Cell Lung Cancer Who Chose Stereotactic Body Radiotherapy Compared to Surgery.” The Journal of Thoracic and Cardiovascular Surgery, vol. 167, no. 3, Mar. 2024, p. 822. EBSCOhost, https://doi.org/10.1016/j.jtcvs.2023.07.021.

APA

Udelsman, B. V., Canavan, M. E., Zhan, P. L., Ely, S., Park, H. S., Boffa, D. J., & Mase, V. J., Jr. (2024). Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. The Journal of Thoracic and Cardiovascular Surgery, 167(3), 822. https://doi.org/10.1016/j.jtcvs.2023.07.021

Chicago

Udelsman, Brooks V, Maureen E Canavan, Peter L Zhan, Sora Ely, Henry S Park, Daniel J Boffa, and Vincent J Mase Jr. 2024. “Overall Survival in Low-Comorbidity Patients with Stage I Non-Small Cell Lung Cancer Who Chose Stereotactic Body Radiotherapy Compared to Surgery.” The Journal of Thoracic and Cardiovascular Surgery 167 (3): 822. doi:10.1016/j.jtcvs.2023.07.021.